Pharmaceuticals and Alcon performed strongly in the first quarter; overall ... Reuters Afinitor (everolimus), an oral inhibitor of the mTOR pathway used across multiple diseases, made a strong contribution to Pharmaceuticals growth in the first quarter with sales of USD 143 million (+60% cc). Everolimus was submitted to regulatory ... |
